Acadia Healthcare Company, Inc. $ACHC Shares Purchased by Northern Trust Corp

Key Points

• Northern Trust Corp increased its stake in Acadia Healthcare by 1.8% during Q1, owning 878,667 shares worth approximately $26.64 million.
• Acadia Healthcare reported a quarterly earnings per share (EPS) of $0.83, exceeding estimates, with revenue of $869.23 million, a 9.2% year-on-year increase.
• Analysts have mixed ratings on Acadia Healthcare, with nine rating it a Buy and four a Hold, alongside a consensus price target of $40.77.

Northern Trust Corp lifted its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 1.8% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 878,667 shares of the company's stock after acquiring an additional 15,601 shares during the period. Northern Trust Corp owned 0.95% of Acadia Healthcare worth $26,641,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd boosted its stake in shares of Acadia Healthcare by 11,218.2% in the first quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company's stock worth $38,000 after acquiring an additional 1,234 shares during the last quarter. UMB Bank n.a. boosted its stake in shares of Acadia Healthcare by 149.5% in the first quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock worth $38,000 after acquiring an additional 755 shares during the last quarter. State of Wyoming acquired a new stake in shares of Acadia Healthcare in the fourth quarter worth approximately $56,000. Covestor Ltd boosted its stake in shares of Acadia Healthcare by 56.0% in the first quarter. Covestor Ltd now owns 2,262 shares of the company's stock worth $69,000 after acquiring an additional 812 shares during the last quarter. Finally, Aquatic Capital Management LLC acquired a new stake in shares of Acadia Healthcare in the fourth quarter worth approximately $97,000.

Acadia Healthcare Price Performance

NASDAQ:ACHC opened at $22.96 on Friday. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.73. The company has a market capitalization of $2.12 billion, a P/E ratio of 15.21, a P/E/G ratio of 4.52 and a beta of 0.88. Acadia Healthcare Company, Inc. has a 52 week low of $17.13 and a 52 week high of $82.40. The stock's fifty day moving average is $22.01 and its two-hundred day moving average is $25.44.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.12. The firm had revenue of $869.23 million for the quarter, compared to the consensus estimate of $839.59 million. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The company's quarterly revenue was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.91 EPS. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. Equities analysts expect that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on ACHC. UBS Group lowered their price objective on Acadia Healthcare from $45.00 to $31.00 and set a "buy" rating on the stock in a research note on Thursday, August 7th. KeyCorp lowered their price objective on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research note on Wednesday, May 14th. Royal Bank Of Canada lowered their price objective on Acadia Healthcare from $43.00 to $28.00 and set an "outperform" rating on the stock in a research note on Wednesday, August 13th. Wall Street Zen raised Acadia Healthcare from a "sell" rating to a "hold" rating in a research note on Sunday, August 3rd. Finally, Stephens raised Acadia Healthcare to a "hold" rating in a research note on Monday, June 2nd. Nine research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, Acadia Healthcare presently has a consensus rating of "Moderate Buy" and an average price target of $40.77.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.